Cholangiohepatitis in Cats: Liver Inflammation and Care

What Is Cholangiohepatitis in Cats?

Cholangiohepatitis cats develop is inflammation of the liver and the bile ducts that pass through it. Bile is produced in the liver, stored in the gallbladder, and released into the small intestine to help digest fat. When the bile ducts become inflamed, they swell, scar, and may obstruct bile flow. Liver cells are simultaneously damaged by the inflammatory process. The result is one of the most common liver diseases in cats and a leading cause of jaundice in feline patients.

The condition exists in three main forms: neutrophilic (often bacterial, sometimes acute), lymphocytic (chronic, immune-mediated), and chronic mixed forms. Cats commonly have inflammatory bowel disease, pancreatitis, and cholangiohepatitis simultaneously, a triad called feline triaditis. Recognizing this overlap is important because treatment must address all the affected systems together.

Most cats respond well to treatment, especially when diagnosed early, but the disease often requires long-term management to prevent recurrence and progression.

Neutrophilic, Lymphocytic, and Mixed Forms

Neutrophilic cholangiohepatitis usually represents an acute or subacute infection, typically with bacteria ascending from the small intestine through the common bile duct. Affected cats can be quite ill with fever, lethargy, vomiting, and jaundice. This form responds well to appropriate antibiotic therapy chosen based on culture, ideally from a bile sample.

Lymphocytic cholangiohepatitis is more chronic and likely represents an immune-mediated process. Cats may show milder, longer-lasting signs: intermittent vomiting, weight loss, appetite changes, and gradually progressive jaundice. Treatment centers on immunosuppression with corticosteroids and supportive care.

Mixed forms blend features of both, sometimes evolving from one to the other over time. The biopsy distinguishes them, which is why histopathology is the gold standard for diagnosis. Treatment may need to combine antimicrobial and immunosuppressive therapy in mixed cases.

Recognizing the Signs

Cats are notorious for hiding illness. The earliest signs of cholangiohepatitis are often nonspecific: decreased appetite, intermittent vomiting, weight loss, or lethargy. These can easily be attributed to another cause or assumed to be a passing problem.

Jaundice is the most specific clue, visible as yellowing of the gums, the whites of the eyes, the skin, or even the inside of the ears. Pale or clay-colored stools also suggest bile flow problems. Some cats develop a fever, abdominal pain (showing as hunched posture or sensitivity when picked up), or hepatic encephalopathy in advanced cases.

Any cat off food for more than a day or two needs a veterinary visit, especially if other signs are present. Cats are particularly vulnerable to hepatic lipidosis (fatty liver) when they stop eating, which can complicate any underlying liver disease and become its own emergency.

Diagnostic Workup

Bloodwork typically shows elevated liver enzymes (ALT, AST, ALP, GGT) and elevated bilirubin causing the visible jaundice. White blood cell count may be elevated in neutrophilic forms. Bile acids may be elevated. Pre-renal or renal involvement may also be noted.

Ultrasound is the most useful imaging tool. It evaluates the liver size, architecture, gallbladder, bile ducts, and surrounding structures. The bile ducts may appear thickened or dilated. Concurrent pancreatitis or intestinal disease may be evident. The gallbladder may contain sludge or stones.

Definitive diagnosis requires a liver biopsy, ideally with bile sampling for culture. Biopsies can be taken laparoscopically, surgically, or by ultrasound-guided needle. Bile culture and sensitivity are the gold standard for choosing antibiotics in neutrophilic cases.

Treatment for Neutrophilic Cholangiohepatitis

Antibiotics chosen based on bile culture (or empirically with broad-spectrum agents until results return) are the foundation. Common choices include amoxicillin-clavulanate, fluoroquinolones, or metronidazole, often in combination. Treatment continues for at least four to six weeks, sometimes longer, with periodic rechecks.

Supportive care matters as much as the antibiotics. Cats need IV fluids if dehydrated, anti-nausea medication, appetite stimulants, and sometimes assisted feeding through an esophagostomy or nasoesophageal tube to prevent hepatic lipidosis. Pain management with appropriate medications reduces stress and supports recovery.

Severe cases with bile duct obstruction may need surgical decompression or stent placement. Most cases respond to medical management, but a minority require procedural intervention. Concurrent pancreatitis needs simultaneous attention, including pain control and feeding support.

Treatment for Lymphocytic Cholangiohepatitis

Corticosteroids (prednisolone) are the mainstay. Cats are typically started on a moderate to higher dose for several weeks, then tapered over months based on clinical response and bloodwork. Prednisolone is preferred over prednisone in cats because of better absorption and metabolism.

Some cats need adjunctive immunosuppression with chlorambucil, azathioprine (with caution in cats), or cyclosporine. These additions allow lower steroid doses and better long-term control. Your veterinarian will tailor the protocol based on response, side effects, and concurrent diseases.

Lymphocytic disease tends to be chronic and recurrent. Many cats need lifelong low-dose immunosuppression to prevent flares. Periodic bloodwork monitors liver function and watches for medication side effects.

Diet and Supportive Care

Diet matters in both forms. Cats need adequate calories and protein to support liver regeneration, but the specific composition depends on the case. Most cats do well on a complete and balanced diet with high-quality, easily digestible protein. Cats with hepatic encephalopathy may need temporary protein restriction, though long-term restriction is rarely needed.

Appetite stimulation is critical. Mirtazapine and capromorelin are commonly prescribed by veterinarians to encourage eating. Hand-feeding warmed food, offering strong-smelling options, and creating a calm environment all help. If the cat refuses to eat, feeding tubes are not a failure; they are a powerful tool to prevent fatty liver and support healing.

SAMe and silymarin are commonly used as supportive supplements. Vitamin K may be needed if coagulation is affected. Ursodiol promotes bile flow and is often prescribed for both forms of disease. Your veterinarian will choose the combination that best fits your cat.

Feline Triaditis

The triad of cholangiohepatitis, pancreatitis, and inflammatory bowel disease is so common in cats that it has its own name: feline triaditis. The three conditions share inflammatory mechanisms and can perpetuate each other through shared anatomy and immune dysregulation. The pancreatic and bile ducts open into the small intestine very close to each other in cats, which is part of why inflammation tends to spread between systems.

If your cat is diagnosed with one component, the others should be considered. Concurrent pancreatitis can be subtle on bloodwork (Spec fPL is the most sensitive test), and IBD often requires biopsy of the small intestine for confirmation. Treating only one component while ignoring the others often leads to incomplete response and frequent relapses.

Combined treatment with attention to all three systems usually provides better long-term outcomes. This may include diet changes, immunosuppression, antibiotics, and ongoing monitoring of all three organs. Many specialists recommend taking biopsies from the liver, pancreas, and small intestine at the same surgical exploration to characterize all three sites at once.

Hepatic Lipidosis Risk

Cats with cholangiohepatitis are at high risk for hepatic lipidosis (fatty liver) if they stop eating, even briefly. Cats mobilize fat to the liver when calorically deficient, and an already inflamed liver cannot process the influx, leading to a secondary disease that compounds the original problem. Once lipidosis is established, recovery is harder and longer.

This is why feeding tubes are recommended early in any cat that is reluctant to eat. An esophagostomy tube allows reliable delivery of complete nutrition and medications, can stay in place for weeks to months, and is generally well tolerated. Owners can administer food at home through the tube, and most cats keep their normal personality and routines despite having one.

The combination of cholangiohepatitis and lipidosis dramatically worsens prognosis if not addressed promptly. Aggressive nutritional support is one of the highest-value interventions in feline liver disease.

Long-Term Outlook

Prognosis depends on the form, severity, and how quickly treatment starts. Acute neutrophilic cases with appropriate antibiotic therapy often resolve completely. Chronic lymphocytic cases tend to require long-term management but many cats live good-quality lives for years.

Recurrent flares are common with lymphocytic disease. Owners should monitor appetite, energy, and jaundice signs continuously. Bloodwork every few months tracks progress and watches for medication side effects.

Some cats develop progressive fibrosis or end-stage liver disease despite optimal management, but the majority do well when the disease is recognized and treated promptly. The first three months after diagnosis are typically the most intensive in terms of monitoring and adjustments.

Related Feline GI and Liver Topics

Cholangiohepatitis sits within a broader picture of feline gastrointestinal and liver disease. Hepatic lipidosis (fatty liver) is a critical consideration for any anorexic cat. IBD, pancreatitis, and lymphoma have overlapping signs and sometimes coexist with cholangiohepatitis.

The cat care blog covers feline GI health, diet decisions, and senior wellness. The adopt a cat hub includes guidance on adopting an adult cat with a chronic condition. Cholangiohepatitis is manageable in most cases and not a barrier to a great match.

Frequently Asked Questions

Is cholangiohepatitis cats develop contagious?

The disease itself is not contagious to other cats or to humans. The bacteria sometimes responsible for neutrophilic cases are typically the cat’s own intestinal flora, not pathogens passed between animals. There is no risk to other household pets.

How is the diagnosis confirmed?

Definitive diagnosis is by liver biopsy, ideally with bile culture in suspected neutrophilic cases. Bloodwork and imaging strongly suggest the diagnosis but cannot reliably differentiate the forms or rule out other causes such as lymphoma without biopsy.

What is the difference between this and hepatic lipidosis?

Hepatic lipidosis (fatty liver) is fat accumulation in liver cells, usually triggered by anorexia. Cholangiohepatitis is inflammation of the liver and bile ducts. They can coexist, especially when an inflammatory disease causes the cat to stop eating. Treatment must address both if they occur together.

Will my cat need lifelong medication?

Acute neutrophilic cases often resolve fully with antibiotics and supportive care. Chronic lymphocytic cases typically need long-term low-dose immunosuppression to prevent flares, and adjunctive supplements are often continued indefinitely. Your vet will tailor the long-term plan to your cat.

Can diet alone treat cholangiohepatitis?

Diet is supportive but not curative on its own. Medications (antibiotics or immunosuppressants depending on form) are essential. Diet supports overall liver function and helps with concurrent IBD or pancreatitis when present.

When should I call my veterinarian?

Call promptly if your cat is jaundiced, off food for more than 24 hours, vomiting, lethargic, or acting unwell. Cholangiohepatitis worsens steadily without treatment, and cats are at high risk for fatty liver if they stop eating. Same-day evaluation is appropriate for any concerning combination of signs.